Optimizing NMR fragment-based drug screening for membrane protein targets

Area of Science:

• Biochemistry
• Structural Biology
• Drug Discovery

Background:

• Nuclear Magnetic Resonance (NMR) spectroscopy is vital for fragment-based drug discovery, enabling detection of ligand-target binding and structural mapping.
• NMR screening is effective for soluble proteins but limited for membrane proteins, which are significant drug targets.
• Challenges include preparing membrane proteins for NMR and managing complex solution NMR spectroscopy with membrane-mimetic agents.

Purpose of the Study:

• To develop a generalizable protocol for fragment-based screening of membrane proteins using NMR.
• To optimize NMR acquisition parameters, protein concentration, and detergent micelle conditions for human membrane proteins.
• To demonstrate the protocol's efficacy in identifying hit compounds against membrane protein targets.

Main Methods:

• Developed a generalizable NMR protocol for fragment-based screening of membrane proteins.
• Utilized two human membrane protein targets, C99 and PMP22, in detergent micelles.
• Optimized NMR parameters, protein-to-micelle ratios, and DMSO concentrations for screening.

Main Results:

• Successfully optimized conditions for NMR screening of C99 and PMP22 in detergent micelles.
• Conducted preliminary fragment screening using optimized conditions.
• Identified hit compounds that selectively bind to the target membrane proteins.

Conclusions:

• The developed NMR protocol is effective for fragment-based screening of membrane proteins.
• This approach can complement existing methods for discovering lead compounds targeting membrane proteins.
• The protocol facilitates drug discovery efforts focused on challenging membrane protein targets.